Skip to content

Indian pharma market registers 9% growth in February

Glaxo Smith Kline#39;s antibiotic drug Augmentin and USV#39;s anti-diabetes medication Glycomet GP continue to lead in sales.

Read More

​ Glaxo Smith Kline#39;s antibiotic drug Augmentin and USV#39;s anti-diabetes medication Glycomet GP continue to lead in sales. Glaxo Smith Kline#39;s antibiotic drug Augmentin and USV#39;s anti-diabetes medication Glycomet GP continue to lead in sales.  Moneycontrol Latest News Read More  

Leave a Reply

en_USEnglish